CVS Health plans to split itself up. Here's why a breakup could make sense now

7 hours ago

Jim Cramer says this bank stock is a buy after its post-election pullback

10 hours ago

CVS falls on plans to split off drugstore business in major breakup

8 hours ago

Novo shares jump as Wegovy pill sales impress, drugmaker hikes outlook

16 hours ago

Pfizer hikes 2026 outlook as new products grow, taps company veteran as new CFO

20 hours ago

Midterm elections could jolt stocks as Democrats look poised to sweep Congress

23 hours ago

A biotech's high-stakes cancer bet just paid off and its shares doubled

1 day ago

Jim Cramer says lower oil prices are giving stocks a boost. Can it last?

1 day ago

Stocks started the week higher but ended in despair. Our take on the big reversal

2 days ago

Cramer's week ahead: Expect more volatility as tech earnings, midterms loom

5 days ago

Gen Z is ditching bars for run clubs — and finding more than friends along the way

5 days ago

A pharma major is touting an MS drug to ease patent-cliff fears

5 days ago

West Pharma: More than a GLP-1 play. The case for further upside

5 days ago

Cramer sees opportunity amid tech turmoil and predicts a holiday win for FedEx

6 days ago

Merck tops estimates, hikes profit outlook on strength of injectable Keytruda

6 days ago

Eli Lilly blows past estimates, hikes sales outlook on resilient GLP-1 demand

6 days ago

GLP-1 coverage is shrinking for 2027. Here are weight-loss options for workers

6 days ago

Measles resurgence exposes deeper weaknesses in U.S. public health, experts say

8 days ago

Cramer: I asked tech insiders what to buy. They surprisingly said this drug stock

8 days ago

Amgen says drug combo slashes risk of death by 58% in patients with lung cancer

9 days ago

Doctors call Moderna, Merck's cancer vaccine data a major advancement

11 days ago

Moderna shares plunge after cancer vaccine data leaks — despite positive results

13 days ago

New bipartisan bill aims to speed up clinical trials for rare disease treatments

13 days ago

Novo's CagriSema obesity drug shows 25% weight loss in women in analysis

13 days ago

Sickle cell gene therapies offer new hope, but access remains a major challenge

19 days ago

Here's our monthly update on our 32 stocks, including 2 more names to buy

20 days ago

Merck CEO tells CNBC he expects cancer vaccine will get faster to make over time

20 days ago

What Maven CEO Kate Ryder tells her kids every day amid AI education threat

21 days ago

Walmart to cover some GLP-1s, inhalers, insulin for employees at no cost

21 days ago

UnitedHealth hikes profit outlook, tops estimates as insurer manages medical costs

22 days ago

Cramer: Starbucks tells me Chipotle takeover won't happen and that's good for the stock

23 days ago

Jim Cramer week ahead: Bank earnings, ASML and TSMC

23 days ago